Surgicure Technologies
Surgicure Technologies is a Boston-based medical device startup developing the HORSESHOE™, a patented off-the-face endotracheal tube securement device for hospital ICUs and military medical applications, targeting prevention of unplanned extubations and facial pressure injuries.
- Company typePrivate
- Founded2024
- HeadquartersCambridge, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Surgicure Technologies does
Surgicure Technologies, Inc. is a Boston-based medical device startup developing the HORSESHOE™, a patented off-the-face horseshoe-shaped endotracheal tube (ET) securement device. The product is constructed from Versaflex™ material and incorporates integrated molar props, an internal support frame, an adjustable ETT clamp with no facial contact, a continuous-spectrum locking mechanism with audible/visual/tactile confirmation, a backup strap D-ring, and an ancillary tubing bracket. It is designed to secure ET tubes sized 6.5mm to 10mm across an estimated 90% of adult patients, including those with facial trauma, burns, facial hair, emaciation, or edema.
The company targets hospital intensive care units (ICUs) and critical care settings as its primary customer segment, with secondary positioning in military medical applications. The value proposition centers on preventing unplanned extubations, eliminating device-related facial pressure injuries (MDRPIs), and facilitating oral care for mechanically ventilated patients. Surgicure aligns its product claims with the 2022 ICHE VAP prevention guidelines and International NPIAP MDRPI prevention guidelines, and provides a custom ROI calculator estimating $664,812 to $1,329,624 in annual cost avoidance for a 344-bed hospital.
Surgicure operates a direct-to-hospital sales motion using enterprise field sales supplemented by a product-led demo/evaluation program and a quote-based pricing model. The HORSESHOE™ is currently in pre-order stage following a $1.785 million seed funding round closed in March 2025, led by Launchpad Venture Group with participation from 12 additional angel and venture investors. The company has 1-10 employees and is led by founder Irena King, PhD, with a board including Cheryl Blanchard, PhD, Carl Winfree, MBA, David Pierce, and Ajibade Ashaye, MD, MBA. Revenue has not yet been disclosed.
Surgicure Technologies firmographics
Firmographics- Name
- Surgicure Technologies
- Legal name
- Surgicure Technologies, Inc.
- Website
- https://surgicuretech.com
- Company type
- Private
- Founded year
- 2024
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Surgicure Technologies is a Boston-based medical device startup developing the HORSESHOE™, a patented off-the-face endotracheal tube securement device for hospital ICUs and military medical applications, targeting prevention of unplanned extubations and facial pressure injuries.
- Ownership category
- akta.pro rank
Surgicure Technologies industry classification
Industry- Product category
- Airway Management Medical Devices
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Airway Management Devices (ET Tubes, LMAs, Tracheostomy, Suction) (HLAHAGAF)
Keywords
Where Surgicure Technologies is headquartered
LocationHeadquarters
- HQ city
- Cambridge
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Surgicure Technologies business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Personnel, Technology or R&D, Marketing or Sales, Supply Chain
Revenue model
- HORSESHOE™ Device Sales: One-time hardware sales of the HORSESHOE™ endotracheal tube securement device to hospitals and healthcare facilities. The device is currently available for pre-orders, with commercialization following the seed funding round. Pricing is quote-based, likely varying by facility size and volume.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Quote-based enterprise pricing |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels7 records
Surgicure Technologies product offering
Product offeringCore offering
Surgicure Technologies designs, patents, and manufactures the HORSESHOE™, a novel off-the-face, horseshoe-shaped endotracheal (ET) tube securement device made of Versaflex™ material. It is intended for use by hospitals and critical care units to securely stabilize ET tubes sized 6.5–10 mm in mechanically ventilated adult patients, while eliminating facial contact and preventing unplanned extubations, medical device-related pressure injuries (MDRPIs), and ventilator-associated pneumonia (VAP). The device is currently available for pre-orders from hospitals and healthcare facilities in the United States.
Product overview
Surgicure Technologies offers the HORSESHOE™ as its core product—a single unified medical device focused on endotracheal tube securement. The HORSESHOE™ is designed to improve airway management and patient safety for both civilian and military healthcare applications. The device replaces outdated ET tube securement methods that can cause dislodgement, pressure injuries, and restricted access to oral care. It features integrated molar props, adjustable ETT clamp, backup strap, and ancillary tubing bracket as key components of the system.
Differentiator
Problem solved
Functional benefit
Products and services
- HORSESHOE™ Endotracheal Tube Securement Device A patented, off-the-face, horseshoe-shaped endotracheal tube securement device made of Versaflex™ material for adult ICU patients. Features integrated molar props, an adjustable 'No Contact' ETT clamp (6.5–10 mm), continuous-spectrum locking mechanism with audible/visual/tactile confirmation, backup strap D-ring, and ancillary tubing bracket. Sold to hospitals and critical care units to prevent unplanned extubations, eliminate facial pressure injuries (MDRPIs), and facilitate oral care.
Quantifiable outcome
- Reduces unplanned extubations by 25-50%, with estimated annual cost avoidance of $368,928-$737,856 for a 344-bed hospital
- +5 more outcomes
Companies that use Surgicure Technologies
Customer profileSegments3 records
Ideal customer profiles2 records
Surgicure Technologies technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Surgicure Technologies partnerships and signals
Strategic signalScale indicators5 records
Recent moves5 records
Expansion highlights4 records
Surgicure Technologies competitors and assessment
Company assessmentDirect peers
- Dale Medical Products: Long-established maker of ET tube holders and stabilization devices (e.g., Dale Stabilock) — the incumbent standard against which HORSESHOE™ is directly positioned and which it aims to displace in ICU securement.
Broad incumbents
- Medtronic: Global medtech incumbent with an extensive airway and respiratory portfolio (post-Covidien acquisition, including Shiley tracheostomy and related critical-care consumables) — broad overlap in ICU airway management customers.
- Teleflex: Diversified medical device manufacturer with a sizeable respiratory and anesthesia airway franchise (Rusch, Hudson RCI, Iso-Gard) — directly relevant to hospital airway consumables buying points.
- Ambu: Single-use device specialist with a leading position in laryngeal masks, bronchoscopes, and other airway management products — competes for the same ICU and anesthesia budgets and shares a single-use consumables model.
- ICU Medical: Following its acquisition of Smiths Medical, ICU Medical offers a portfolio of airway management and critical-care consumables sold to the same hospital procurement and clinical stakeholders as Surgicure.
- Vyaire Medical: Pure-play respiratory care company spanning ventilation, anesthesia delivery, and airway consumables — comparable customer base (hospital respiratory therapy and ICU) and overlapping product category.
- Intersurgical: European-headquartered manufacturer of airway management devices, anesthesia consumables, and respiratory care products — competes in adjacent airway securement and critical-care device categories.
- Cook Medical: Privately held medical device manufacturer with a significant airway, critical care, and endoscopy portfolio — comparable hospital enterprise sales motion and adjacent to ET tube and tracheostomy securement.
- Laerdal Medical: Global airway management and resuscitation company with both training/simulation products and clinical airway devices — comparable customer base in hospitals and anesthesia/critical-care training programs.
Emerging players
- Verathon: Roper Technologies-owned specialty medtech focused on airway visualization (GlideScope video laryngoscopes) — complementary rather than direct, but competes for the same anesthesiologist and intensivist stakeholders and budgets.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights7 records
Customer concentration
Surgicure Technologies social profiles
Digital presenceSurgicure Technologies financial estimates
Financial estimateRevenue estimate
Valuation estimate
Surgicure Technologies leadership team
Management profileNumber of profiles
Profiles5 records
Surgicure Technologies funding detail
Funding detailFunding overview
Funding rounds2 records
Investors9 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Surgicure Technologies M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Surgicure Technologies
What does Surgicure Technologies do?
Surgicure Technologies designs, patents, and manufactures the HORSESHOE™, a novel off-the-face, horseshoe-shaped endotracheal (ET) tube securement device made of Versaflex™ material. It is intended for use by hospitals and critical care units to securely stabilize ET tubes sized 6.5–10 mm in mechanically ventilated adult patients, while eliminating facial contact and preventing unplanned extubations, medical device-related pressure injuries (MDRPIs), and ventilator-associated pneumonia (VAP). The device is currently available for pre-orders from hospitals and healthcare facilities in the United States.
Is Surgicure Technologies a public or private company?
Surgicure Technologies is a private company. It is classified as venture growth investor backed and is currently operating.
When was Surgicure Technologies founded?
Surgicure Technologies was founded in 2024. It employs 1 to 10 people.
Where is Surgicure Technologies based?
Surgicure Technologies is headquartered in Cambridge, United States, in the North America region.
How does Surgicure Technologies make money?
One revenue line is on record: HORSESHOE™ Device Sales.
Who are Surgicure Technologies's main competitors?
Dale Medical Products is listed as a direct peer. Broad incumbents are Medtronic, Teleflex, Ambu, ICU Medical, Vyaire Medical, Intersurgical, Cook Medical and Laerdal Medical. Verathon is listed as an emerging player.
Does Surgicure Technologies have an API?
No public API is recorded for Surgicure Technologies.
What industry is Surgicure Technologies in?
Surgicure Technologies's product category is Airway Management Medical Devices. Its primary akta.pro industry code is HLAHAGAF, Airway Management Devices (ET Tubes, LMAs, Tracheostomy, Suction). Its NAICS code is 339113 and its SIC code is 3841.